BICLUSTER_ID : UPREG-20
PATHOGENS /3/ : escherichia coli,streptococcus pneumoniae,mycobacterium tuberculosis
TARGETS /13/ : NFKB1, STAT1, ABCC1, WARS, CCL8, IL6, PTGS2, AMPD3, ICAM1, IL8, PIM1, TXNRD1, CFB
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPNR4A3, NFKBIE, HBEGF, FOSL1, CXCL3, NFKBIA, AMPD3, TNFRSF11B, UST, PSMA3, INHBA, CXCL2, SLC25A28, TXNRD1, SOD2, CFB, NFKB1, BIRC3, CXCL1, WARS, CCL8, JMJD3, TNFAIP6, IL6, PTGS2, ICAM1, IL8
NETPATH TNF ALPHA PATHWAY DOWNHIF1A, RGS16, CXCL3, NFKBIA, EXT1, CXCL2, BHLHB2, IER3, NFKB1, KLF6, INSIG1, CXCL1, TRADD, FOSB, CLEC2B, KLF10, TNFSF10, MAFF, GEM, IL6, TNFAIP3, PTGS2, IRF1
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, CXCL1, ABCC1, CEBPB, MAP3K8, NMI, MAFF, TNFRSF11B, PIM1, IRF1, PRDM1, BHLHB2
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
MAHAJAN RESPONSE TO IL1A UP
PUJANA BRCA2 PCC NETWORK
WEINMANN ADAPTATION TO HYPOXIA DN
BIOCARTA IL6 PATHWAY
LINDGREN BLADDER CANCER CLUSTER 2B
VANHARANTA UTERINE FIBROID DN
BROWNE HCMV INFECTION 20HR UP
VARELA ZMPSTE24 TARGETS UP
ONDER CDH1 TARGETS 2 UP
NCI TNFPATHWAY
LINDSTEDT DENDRITIC CELL MATURATION B
NCI HOST INTERACTIONS OF HIV FACTORS
BRUECKNER TARGETS OF MIRLET7A3 DN
RASHI RESPONSE TO IONIZING RADIATION 2
NUYTTEN EZH2 TARGETS DN
LIEN BREAST CARCINOMA METAPLASTIC VS DUCTAL UP
SESTO RESPONSE TO UV C0
IYENGAR RESPONSE TO ADIPOCYTE FACTORS
AMIT EGF RESPONSE 40 HELA
KIM WT1 TARGETS 12HR DN
NETPATH IL 7 PATHWAY UP
JEON SMAD6 TARGETS UP
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21
NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21
MITSIADES RESPONSE TO APLIDIN UP
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
RUTELLA RESPONSE TO CSF2RB AND IL4 UP
HINATA NFKB TARGETS KERATINOCYTE UP
CORUM PA28GAMMA-20S PROTEASOME
KOKKINAKIS METHIONINE DEPRIVATION 96HR UP
MARKEY RB1 ACUTE LOF UP
REN ALVEOLAR RHABDOMYOSARCOMA DN
AMIT SERUM RESPONSE 60 MCF10A
COULOUARN TEMPORAL TGFB1 SIGNATURE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS MAGENTA UP
HAN SATB1 TARGETS DN
HUANG FOXA2 TARGETS UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION MONOCYTE UP
BIOCARTA CD40 PATHWAY
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLUE UP
AMIT EGF RESPONSE 120 HELA
BIOCARTA RANKL PATHWAY
DANG REGULATED BY MYC DN
REACTOME APOPTOSIS
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
GAJATE RESPONSE TO TRABECTEDIN UP
SHAFFER IRF4 TARGETS IN PLASMA CELL VS MATURE B LYMPHOCYTE
PODAR RESPONSE TO ADAPHOSTIN UP
HOSHIDA LIVER CANCER SUBCLASS S1
KYNG DNA DAMAGE UP
KIM MYC AMPLIFICATION TARGETS DN
LEE LIVER CANCER E2F1 UP
WANG SMARCE1 TARGETS DN
KERLEY RESPONSE TO CISPLATIN UP
HELLER SILENCED BY METHYLATION UP
GOZGIT ESR1 TARGETS DN
NETPATH TGFBETA RECEPTOR PATHWAY DOWN
VANTVEER BREAST CANCER ESR1 DN
PUIFFE INVASION INHIBITED BY ASCITES DN
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
GERY CEBP TARGETS
NCI P53DOWNSTREAMPATHWAY
SPIRA SMOKERS LUNG CANCER UP
MODY HIPPOCAMPUS NEONATAL
ST TUMOR NECROSIS FACTOR PATHWAY
TAKAO RESPONSE TO UVB RADIATION DN
CHASSOT SKIN WOUND
TIAN TNF SIGNALING VIA NFKB
CHARAFE BREAST CANCER BASAL VS MESENCHYMAL DN
HUMMEL BURKITTS LYMPHOMA DN
NCI VIF MEDIATED DEGRADATION OF APOBEC3G
GENTILE UV LOW DOSE UP
KEGG APOPTOSIS
NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
LEE EARLY T LYMPHOCYTE DN
HUANG DASATINIB RESISTANCE UP
PEREZ TP63 TARGETS
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
HINATA NFKB TARGETS FIBROBLAST UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL DN
MISSIAGLIA REGULATED BY METHYLATION UP
NCI ATF2 PATHWAY
KOYAMA SEMA3B TARGETS DN
GEORGANTAS HSC MARKERS
BROWNE HCMV INFECTION 12HR UP
SESTO RESPONSE TO UV C1
CROONQUIST STROMAL STIMULATION UP
ZHANG RESPONSE TO CANTHARIDIN UP
BLUM RESPONSE TO SALIRASIB UP
BOYLAN MULTIPLE MYELOMA D DN
KHETCHOUMIAN TRIM24 TARGETS UP
MAHADEVAN GIST MORPHOLOGICAL SWITCH
BIOCARTA CDMAC PATHWAY
HORIUCHI WTAP TARGETS UP
WOO LIVER CANCER RECURRENCE UP
CORUM PA28-20S PROTEASOME
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS UP
NCI LYSOPHOSPHOLIPID PATHWAY
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS GREY DN
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS BLACK UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
DIRMEIER LMP1 RESPONSE LATE UP
GILDEA METASTASIS
AMIT EGF RESPONSE 20 HELA
GALI TP53 TARGETS APOPTOTIC UP
HOUSTIS ROS
BASSO CD40 SIGNALING UP
BIOCARTA NTHI PATHWAY
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
CHIBA RESPONSE TO TSA DN
ENK UV RESPONSE EPIDERMIS DN
ZERBINI RESPONSE TO SULINDAC UP
FRASOR RESPONSE TO ESTRADIOL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
FRIDMAN SENESCENCE UP
CROMER TUMORIGENESIS UP
FERRARI RESPONSE TO FENRETINIDE UP
PUJANA XPRSS INT NETWORK
SANA RESPONSE TO IFNG UP
HOEBEKE LYMPHOID STEM CELL DN
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
MARTINEZ RESPONSE TO TRABECTEDIN UP
NCI NF KB IS ACTIVATED AND SIGNALS SURVIVAL
CHEN HOXA5 TARGETS 9HR UP
KANNAN TP53 TARGETS UP
NETPATH IL 5 PATHWAY UP
RORIE TARGETS OF EWSR1 FLI1 FUSION UP
SENGUPTA NASOPHARYNGEAL CARCINOMA WITH LMP1 UP
SEKI INFLAMMATORY RESPONSE LPS UP
NETPATH EGFR1 PATHWAY UP
DAZARD UV RESPONSE CLUSTER G24
GRAHAM CML QUIESCENT VS CML DIVIDING UP
CONCANNON APOPTOSIS BY EPOXOMICIN UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
LEE RECENT THYMIC EMIGRANT
MURAKAMI UV RESPONSE 6HR UP
BUYTAERT PHOTODYNAMIC THERAPY STRESS UP
NCI UBIQUITIN DEPENDENT DEGRADATION OF CYCLIN D1
SHI SPARC TARGETS UP
WANG METHYLATED IN BREAST CANCER
CORUM 20S PROTEASOME
CORUM 26S PROTEASOME
SENESE HDAC1 TARGETS UP
INGA TP53 TARGETS
KIM WT1 TARGETS UP
REACTOME P75NTR SIGNALS VIA NFKB
ONDER CDH1 TARGETS 1 DN
LINDSTEDT DENDRITIC CELL MATURATION C
HESS TARGETS OF HOXA9 AND MEIS1 DN
CROONQUIST NRAS SIGNALING UP
ELVIDGE HYPOXIA BY DMOG UP
IIZUKA RECURRENT LIVER CANCER
NETPATH WNT PATHWAY UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
JIANG TIP30 TARGETS UP
MAHADEVAN IMATINIB RESISTANCE UP
NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A
BERENJENO ROCK SIGNALING NOT VIA RHOA DN
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
KIM WT1 TARGETS 8HR UP
KOBAYASHI RESPONSE TO ROMIDEPSIN
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
ELVIDGE HIF1A TARGETS DN
LI CISPLATIN RESISTANCE DN
NETPATH IL 5 PATHWAY
LENAOUR DENDRITIC CELL MATURATION UP
HAHTOLA MYCOSIS FUNGOIDES UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
TENEDINI MEGAKARYOCYTE MARKERS
CHEN LVAD SUPPORT OF FAILING HEART UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION GRANULOCYTE UP
LINDSTEDT DENDRITIC CELL MATURATION A
NETPATH IL 1 PATHWAY
ELVIDGE HYPOXIA UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
SESTO RESPONSE TO UV C2
BROWNE INTERFERON RESPONSIVE GENES
NCI IL6 7PATHWAY
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION SUSTAINDED IN ERYTHROCYTE UP
KONDO EZH2 TARGETS
NUYTTEN NIPP1 TARGETS UP
ST TYPE I INTERFERON PATHWAY
FRIDMAN IMMORTALIZATION DN
KAAB FAILED HEART VENTRICLE DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
DAZARD UV RESPONSE CLUSTER G3
XU HGF TARGETS INDUCED BY AKT1 48HR UP
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
BOYAULT LIVER CANCER SUBCLASS G6 DN
DUTTA APOPTOSIS VIA NFKB
SMITH TERT TARGETS DN
TSAI RESPONSE TO IONIZING RADIATION
DELYS THYROID CANCER UP
DIRMEIER LMP1 RESPONSE EARLY
SEMENZA HIF1 TARGETS
NCI VPU MEDIATED DEGRADATION OF CD4
ZHAN V1 LATE DIFFERENTIATION GENES UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
ONDER CDH1 TARGETS 3 DN
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS RED UP
HELLEBREKERS SILENCED DURING TUMOR ANGIOGENESIS
LU AGING BRAIN DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
WINTER HYPOXIA METAGENE
NETPATH TNF ALPHA PATHWAY
NEWMAN ERCC6 TARGETS UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS TURQUOISE UP
TAVOR CEBPA TARGETS UP
FOSTER INFLAMMATORY RESPONSE LPS DN
REACTOME P53 INDEPENDENT DNA DAMAGE RESPONSE
BOYAULT LIVER CANCER SUBCLASS G2
LU TUMOR VASCULATURE UP
OSAWA TNF TARGETS
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
NETPATH TNF ALPHA PATHWAY UP
GESERICK TERT TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 120 MCF10A
BROWNE HCMV INFECTION 2HR UP
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE
NCI IL1PATHWAY
SESTO RESPONSE TO UV C3
BIOCARTA 41BB PATHWAY
WAMUNYOKOLI OVARIAN CANCER GRADES 1 2 DN
VETTER TARGETS OF PRKCA AND ETS1 UP
TURASHVILI BREAST LOBULAR CARCINOMA VS LOBULAR NORMAL DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
GENTILE UV HIGH DOSE DN
ROZANOV MMP14 TARGETS UP
GRUETZMANN PANCREATIC CANCER UP
NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
OKUMURA INFLAMMATORY RESPONSE LPS
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1
KEGG PROTEASOME
LEE LIVER CANCER HEPATOBLAST
NAGASHIMA EGF SIGNALING UP
AMIT DELAYED EARLY GENES
AMIT EGF RESPONSE 60 MCF10A
NOJIMA SFRP2 TARGETS UP
WAMUNYOKOLI OVARIAN CANCER LMP DN
CHEN HOXA5 TARGETS 6HR UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI TCRCALCIUMPATHWAY
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NETPATH EGFR1 PATHWAY DOWN
RODWELL AGING KIDNEY NO BLOOD UP
NCI PDGFRAPATHWAY
RODRIGUES THYROID CARCINOMA DN
NCI NFKAPPABATYPICALPATHWAY
SHARMA PILOCYTIC ASTROCYTOMA LOCATION UP
LEE LIVER CANCER DENA UP
HALMOS CEBPA TARGETS UP
WU CELL MIGRATION
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
CHANDRAN METASTASIS DN
BEIER GLIOMA STEM CELL DN
ONDER CDH1 SIGNALING VIA CTNNB1
CAIRO HEPATOBLASTOMA CLASSES DN
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
MAHADEVAN RESPONSE TO MP470 DN
DORN ADENOVIRUS INFECTION 12HR DN
RIZKI TUMOR INVASIVENESS 2D UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
KOKKINAKIS METHIONINE DEPRIVATION 48HR UP
KAN RESPONSE TO ARSENIC TRIOXIDE
SWEET LUNG CANCER KRAS DN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
LAIHO COLORECTAL CANCER SERRATED UP
REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES
SOUCEK MYC TARGETS
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS LIGHTYELLOW UP
BILBAN B CLL LPL DN
KEGG B CELL RECEPTOR SIGNALING PATHWAY
IZADPANAH STEM CELL ADIPOSE VS BONE UP
GENTILE UV LOW DOSE DN
ZHAN MULTIPLE MYELOMA LB DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
KEGG EPITHELIAL CELL SIGNALING IN HELICOBACTER PYLORI INFECTION
SHAFFER IRF4 MULTIPLE MYELOMA PROGRAM
BILD HRAS ONCOGENIC SIGNATURE
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR DN
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
MENSE HYPOXIA UP
LEE LIVER CANCER ACOX1 UP
BERENJENO TRANSFORMED BY RHOA FOREVER DN
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
AMIT EGF RESPONSE 60 HELA
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION DN
DAZARD UV RESPONSE CLUSTER G2
LEE SP4 THYMOCYTE
AMUNDSON RESPONSE TO ARSENITE
AMIT SERUM RESPONSE 40 MCF10A
GUENTHER GROWTH SPHERICAL VS ADHERENT DN
HELLER HDAC TARGETS SILENCED BY METHYLATION UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
GAUSSMANN MLL AF4 FUSION TARGETS F UP
SANA TNF SIGNALING UP
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
ONDER CDH1 TARGETS 2 DN
NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC
REACTOME STABILIZATION OF P53
MANALO HYPOXIA UPGADD45B, ZHX2, MAFF, INHBA, COL4A2, ADM, HES1, BHLHB2, HIVEP2
CASTELLANO NRAS TARGETS UP
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
SENESE HDAC3 TARGETS UP
VECCHI GASTRIC CANCER ADVANCED VS EARLY UP
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
BIOCARTA KERATINOCYTE PATHWAY
JISON SICKLE CELL DISEASE UP
NCI NFKAPPABCANONICALPATHWAY
XU HGF SIGNALING NOT VIA AKT1 48HR UP
DASU IL6 SIGNALING UP
FARMER BREAST CANCER CLUSTER 2
NETPATH IL 2 PATHWAY UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION
ZUCCHI METASTASIS DN
NUNODA RESPONSE TO DASATINIB IMATINIB DN
BRUECKNER TARGETS OF MIRLET7A3 UP
BEGUM TARGETS OF PAX3 FOXO1 FUSION UP
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
FERRANDO T ALL WITH MLL ENL FUSION UP
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
streptococcus pneumoniae g54mycobacterium tuberculosisescherichia coliGeneSet Name
0.02186 0.00602 0.00000NETPATH_IL_1_PATHWAY_UP
0.00809 0.00002 0.00002NETPATH_TNF_ALPHA_PATHWAY_DOWN
0.01842 0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.03257 0.00002 0.00000GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.08911 0.00132 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.10181 0.00000 0.00000PUJANA_BRCA2_PCC_NETWORK
0.00875 0.03354 0.00000WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.06093 0.06335 0.02803BIOCARTA_IL6_PATHWAY
0.08248 0.00120 0.01415LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.00677 0.00382 0.00612VANHARANTA_UTERINE_FIBROID_DN
0.18330 0.04555 0.07491BROWNE_HCMV_INFECTION_20HR_UP
0.01900 0.00035 0.01038VARELA_ZMPSTE24_TARGETS_UP
0.02667 0.19498 0.12574ONDER_CDH1_TARGETS_2_UP
0.16078 0.01252 0.00010NCI_TNFPATHWAY
0.00817 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.04816 0.00787 0.08644NCI_HOST_INTERACTIONS_OF_HIV_FACTORS
0.00199 0.02642 0.01145BRUECKNER_TARGETS_OF_MIRLET7A3_DN
0.00271 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.05540 0.00000 0.00000NUYTTEN_EZH2_TARGETS_DN
0.04813 0.00196 0.00127LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP
0.00808 0.00205 0.01275SESTO_RESPONSE_TO_UV_C0
0.03272 0.00217 0.00026IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS
0.02615 0.00000 0.00000AMIT_EGF_RESPONSE_40_HELA
0.06314 0.11206 0.06575KIM_WT1_TARGETS_12HR_DN
0.11486 0.00856 0.00000NETPATH_IL_7_PATHWAY_UP
0.02288 0.00136 0.00031JEON_SMAD6_TARGETS_UP
0.09247 0.07509 0.15073REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.08690 0.01422 0.09524NCI_SCF_SKP2__MEDIATED_DEGRADATION_OF_P27_P21
0.00669 0.00000 0.02480MITSIADES_RESPONSE_TO_APLIDIN_UP
0.09013 0.00000 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.13995 0.00000 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00276 0.00000 0.00016RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP
0.00568 0.00000 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.11893 0.08660 0.01008CORUM_PA28GAMMA-20S_PROTEASOME
0.02436 0.02144 0.00331KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP
0.10730 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00269 0.00912 0.08237REN_ALVEOLAR_RHABDOMYOSARCOMA_DN
0.00321 0.00001 0.00109AMIT_SERUM_RESPONSE_60_MCF10A
0.00641 0.02560 0.01809COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP
0.00558 0.00022 0.02827GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP
0.04828 0.00017 0.01800HAN_SATB1_TARGETS_DN
0.08226 0.10555 0.00285HUANG_FOXA2_TARGETS_UP
0.00390 0.00477 0.10906RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN
0.09373 0.00018 0.01141TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP
0.09309 0.01971 0.00009BIOCARTA_CD40_PATHWAY
0.00340 0.00116 0.00143RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.01216 0.00000 0.00155GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP
0.01466 0.00000 0.00046AMIT_EGF_RESPONSE_120_HELA
0.11238 0.03099 0.05932BIOCARTA_RANKL_PATHWAY
0.07999 0.00880 0.02480DANG_REGULATED_BY_MYC_DN
0.15199 0.05314 0.00050REACTOME_APOPTOSIS
0.00715 0.00299 0.00949FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00696 0.00756 0.00098GAJATE_RESPONSE_TO_TRABECTEDIN_UP
0.03041 0.00911 0.05575SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE
0.00016 0.00000 0.01026PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.08375 0.00095 0.10124HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00926 0.00460 0.03420KYNG_DNA_DAMAGE_UP
0.05295 0.10548 0.05243KIM_MYC_AMPLIFICATION_TARGETS_DN
0.05639 0.00014 0.00843LEE_LIVER_CANCER_E2F1_UP
0.03606 0.02317 0.06905WANG_SMARCE1_TARGETS_DN
0.01965 0.04549 0.11052KERLEY_RESPONSE_TO_CISPLATIN_UP
0.17361 0.00000 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.03000 0.00047 0.00791GOZGIT_ESR1_TARGETS_DN
0.14788 0.03994 0.06355NETPATH_TGFBETA_RECEPTOR_PATHWAY_DOWN
0.05316 0.02147 0.00141VANTVEER_BREAST_CANCER_ESR1_DN
0.00111 0.01697 0.06075PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN
0.12533 0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.09635 0.00000 0.00002BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.12493 0.00000 0.01389GERY_CEBP_TARGETS
0.06541 0.08955 0.00831NCI_P53DOWNSTREAMPATHWAY
0.02072 0.04454 0.15123SPIRA_SMOKERS_LUNG_CANCER_UP
0.07529 0.05033 0.19764MODY_HIPPOCAMPUS_NEONATAL
0.10551 0.00010 0.00026ST_TUMOR_NECROSIS_FACTOR_PATHWAY
0.02276 0.00015 0.01190TAKAO_RESPONSE_TO_UVB_RADIATION_DN
0.03610 0.00066 0.17603CHASSOT_SKIN_WOUND
0.16057 0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.00439 0.07062 0.03462CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN
0.05491 0.00035 0.00005HUMMEL_BURKITTS_LYMPHOMA_DN
0.03365 0.00789 0.09578NCI_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.16976 0.17564 0.11450GENTILE_UV_LOW_DOSE_UP
0.08578 0.16900 0.00000KEGG_APOPTOSIS
0.05961 0.00348 0.13163NCI_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX
0.06967 0.00023 0.04462LEE_EARLY_T_LYMPHOCYTE_DN
0.00242 0.00030 0.00046HUANG_DASATINIB_RESISTANCE_UP
0.12701 0.16246 0.07744PEREZ_TP63_TARGETS
0.06179 0.00205 0.00492CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.02432 0.00000 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00034 0.00002 0.00000CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00020 0.00827 0.13173NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN
0.00810 0.00000 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.03036 0.06127 0.01874NCI_ATF2_PATHWAY
0.05711 0.07394 0.18767KOYAMA_SEMA3B_TARGETS_DN
0.01832 0.00021 0.01122GEORGANTAS_HSC_MARKERS
0.10890 0.00050 0.01673BROWNE_HCMV_INFECTION_12HR_UP
0.00828 0.01198 0.00038SESTO_RESPONSE_TO_UV_C1
0.09861 0.00025 0.00003CROONQUIST_STROMAL_STIMULATION_UP
0.03275 0.00019 0.09441ZHANG_RESPONSE_TO_CANTHARIDIN_UP
0.00392 0.00143 0.11927BLUM_RESPONSE_TO_SALIRASIB_UP
0.06977 0.04261 0.13163BOYLAN_MULTIPLE_MYELOMA_D_DN
0.02156 0.00000 0.02879KHETCHOUMIAN_TRIM24_TARGETS_UP
0.12526 0.02942 0.05005MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH
0.16806 0.12581 0.02242BIOCARTA_CDMAC_PATHWAY
0.00695 0.00000 0.00002HORIUCHI_WTAP_TARGETS_UP
0.02446 0.00002 0.01595WOO_LIVER_CANCER_RECURRENCE_UP
0.08304 0.01169 0.00140CORUM_PA28-20S_PROTEASOME
0.10354 0.00000 0.00057ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.03089 0.00000 0.12734RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00923 0.01412 0.01449DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP
0.17451 0.01318 0.09447NCI_LYSOPHOSPHOLIPID_PATHWAY
0.03664 0.00033 0.00379GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN
0.00687 0.00014 0.04300MORI_PRE_BI_LYMPHOCYTE_DN
0.11870 0.00000 0.00000DER_IFN_BETA_RESPONSE_UP
0.07134 0.00033 0.17907GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP
0.01803 0.00000 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.03948 0.04845 0.02986NETPATH_IL_6_PATHWAY
0.06964 0.00003 0.00000DIRMEIER_LMP1_RESPONSE_LATE_UP
0.10751 0.06095 0.10376GILDEA_METASTASIS
0.04591 0.00486 0.00089AMIT_EGF_RESPONSE_20_HELA
0.11520 0.17731 0.04486GALI_TP53_TARGETS_APOPTOTIC_UP
0.11831 0.02752 0.11100HOUSTIS_ROS
0.03498 0.00000 0.00000BASSO_CD40_SIGNALING_UP
0.04158 0.00063 0.00024BIOCARTA_NTHI_PATHWAY
0.00388 0.00011 0.00702TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00022 0.00000 0.00000NAGASHIMA_NRG1_SIGNALING_UP
0.16651 0.00127 0.00002MARZEC_IL2_SIGNALING_UP
0.17824 0.04027 0.00034CHIBA_RESPONSE_TO_TSA_DN
0.00387 0.00582 0.02283ENK_UV_RESPONSE_EPIDERMIS_DN
0.09092 0.04554 0.02814ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00187 0.05936 0.02658FRASOR_RESPONSE_TO_ESTRADIOL_DN
0.10110 0.00019 0.00496WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.03706 0.00067 0.00001FRIDMAN_SENESCENCE_UP
0.02045 0.01999 0.00002CROMER_TUMORIGENESIS_UP
0.01205 0.00018 0.00016FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.19215 0.00000 0.00000PUJANA_XPRSS_INT_NETWORK
0.15101 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.06776 0.01319 0.06971HOEBEKE_LYMPHOID_STEM_CELL_DN
0.05320 0.00468 0.04833REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.02602 0.00534 0.00000ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.05063 0.01686 0.02354MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
0.17477 0.03247 0.00474NCI_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL
0.00050 0.00006 0.00050CHEN_HOXA5_TARGETS_9HR_UP
0.00648 0.10269 0.02721KANNAN_TP53_TARGETS_UP
0.07746 0.00000 0.00001NETPATH_IL_5_PATHWAY_UP
0.04298 0.14786 0.07388RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP
0.08290 0.05282 0.01456SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP
0.02093 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.11210 0.01945 0.00008NETPATH_EGFR1_PATHWAY_UP
0.03319 0.18546 0.17607DAZARD_UV_RESPONSE_CLUSTER_G24
0.11160 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.01005 0.00028 0.08735CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP
0.15242 0.00026 0.11638PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.09093 0.00813 0.17730LEE_RECENT_THYMIC_EMIGRANT
0.16966 0.17085 0.09309MURAKAMI_UV_RESPONSE_6HR_UP
0.00031 0.00001 0.01185BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP
0.04818 0.00551 0.03879NCI_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1
0.01555 0.11302 0.01449SHI_SPARC_TARGETS_UP
0.02474 0.01939 0.00010WANG_METHYLATED_IN_BREAST_CANCER
0.11176 0.05869 0.01632CORUM_20S_PROTEASOME
0.07300 0.01696 0.06610CORUM_26S_PROTEASOME
0.05349 0.04425 0.00079SENESE_HDAC1_TARGETS_UP
0.13640 0.12410 0.02526INGA_TP53_TARGETS
0.00273 0.00007 0.00002KIM_WT1_TARGETS_UP
0.13024 0.00334 0.00047REACTOME_P75NTR_SIGNALS_VIA_NFKB
0.07758 0.07350 0.00021ONDER_CDH1_TARGETS_1_DN
0.00761 0.15036 0.00116LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.13868 0.00000 0.08966HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.17404 0.00175 0.12202CROONQUIST_NRAS_SIGNALING_UP
0.00018 0.00043 0.01098ELVIDGE_HYPOXIA_BY_DMOG_UP
0.08004 0.01895 0.02641IIZUKA_RECURRENT_LIVER_CANCER
0.14364 0.00813 0.00227NETPATH_WNT_PATHWAY_UP
0.01851 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.10106 0.00002 0.00008BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.05661 0.02374 0.05840JIANG_TIP30_TARGETS_UP
0.07766 0.00265 0.00007MAHADEVAN_IMATINIB_RESISTANCE_UP
0.04458 0.01224 0.11597NCI_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A
0.10586 0.00059 0.01676BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN
0.00850 0.00000 0.00005RUTELLA_RESPONSE_TO_HGF_UP
0.06801 0.07998 0.14286HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.00000 0.00000 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.01014 0.00125 0.07735KIM_WT1_TARGETS_8HR_UP
0.03353 0.00458 0.05937KOBAYASHI_RESPONSE_TO_ROMIDEPSIN
0.00267 0.00000 0.02690PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.07009 0.03057 0.08745YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1
0.00071 0.04594 0.11828ELVIDGE_HIF1A_TARGETS_DN
0.04065 0.07997 0.01079LI_CISPLATIN_RESISTANCE_DN
0.04700 0.02988 0.04832NETPATH_IL_5_PATHWAY
0.09690 0.00016 0.14694LENAOUR_DENDRITIC_CELL_MATURATION_UP
0.01835 0.00098 0.02382HAHTOLA_MYCOSIS_FUNGOIDES_UP
0.13820 0.00165 0.03638MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.11247 0.13556 0.00011TENEDINI_MEGAKARYOCYTE_MARKERS
0.01145 0.00015 0.00159CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.16419 0.07363 0.14713TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP
0.16372 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.03624 0.03544 0.00003NETPATH_IL_1_PATHWAY
0.00034 0.00052 0.01124ELVIDGE_HYPOXIA_UP
0.03309 0.05325 0.03327YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.01362 0.00749 0.01450SESTO_RESPONSE_TO_UV_C2
0.11107 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.10802 0.00288 0.00785NCI_IL6_7PATHWAY
0.14828 0.00199 0.00807TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP
0.04692 0.04666 0.18326KONDO_EZH2_TARGETS
0.00315 0.00000 0.00110NUYTTEN_NIPP1_TARGETS_UP
0.04474 0.06313 0.13309ST_TYPE_I_INTERFERON_PATHWAY
0.07577 0.00089 0.00651FRIDMAN_IMMORTALIZATION_DN
0.07614 0.01362 0.06884KAAB_FAILED_HEART_VENTRICLE_DN
0.17463 0.00060 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03860 0.02412 0.00510DAZARD_UV_RESPONSE_CLUSTER_G3
0.18837 0.00027 0.00136XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP
0.03295 0.00021 0.00002OSADA_ASCL1_TARGETS_DN
0.00276 0.00000 0.00000NUYTTEN_EZH2_TARGETS_UP
0.02432 0.00028 0.04843BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN
0.05455 0.00002 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.06576 0.00168 0.08600SMITH_TERT_TARGETS_DN
0.03105 0.00008 0.00126TSAI_RESPONSE_TO_IONIZING_RADIATION
0.05377 0.00018 0.00200DELYS_THYROID_CANCER_UP
0.08905 0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.17257 0.04672 0.14703SEMENZA_HIF1_TARGETS
0.07354 0.00707 0.13037NCI_VPU_MEDIATED_DEGRADATION_OF_CD4
0.07579 0.04074 0.00777ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.11282 0.00002 0.00000ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.01828 0.00000 0.01985RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.03102 0.10086 0.00000ONDER_CDH1_TARGETS_3_DN
0.09080 0.09081 0.11790GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP
0.16628 0.00036 0.00004HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS
0.00736 0.10893 0.01604LU_AGING_BRAIN_DN
0.13119 0.02002 0.00438NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.01549 0.00019 0.02164WINTER_HYPOXIA_METAGENE
0.02401 0.07034 0.00219NETPATH_TNF_ALPHA_PATHWAY
0.04821 0.00177 0.00184NEWMAN_ERCC6_TARGETS_UP
0.01570 0.00000 0.10160GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP
0.04868 0.00011 0.00020TAVOR_CEBPA_TARGETS_UP
0.01680 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.05824 0.01493 0.13847REACTOME_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE
0.11178 0.12852 0.04761BOYAULT_LIVER_CANCER_SUBCLASS_G2
0.16618 0.00083 0.00003LU_TUMOR_VASCULATURE_UP
0.00719 0.07502 0.00142OSAWA_TNF_TARGETS
0.02405 0.00117 0.00071SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.09361 0.00092 0.10200PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.07319 0.00534 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.00310 0.00002 0.00083GESERICK_TERT_TARGETS_DN
0.17024 0.03737 0.10958KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00320 0.00013 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.04469 0.00000 0.00014BROWNE_HCMV_INFECTION_2HR_UP
0.11131 0.02161 0.11712REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE
0.18632 0.01300 0.00686NCI_IL1PATHWAY
0.01104 0.00000 0.00001SESTO_RESPONSE_TO_UV_C3
0.19974 0.03649 0.00135BIOCARTA_41BB_PATHWAY
0.05027 0.13774 0.13262WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN
0.06778 0.15327 0.10170VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP
0.12555 0.05137 0.02251TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN
0.03258 0.00000 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.03598 0.00000 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.00382 0.13562 0.15382GENTILE_UV_HIGH_DOSE_DN
0.08267 0.00007 0.02679ROZANOV_MMP14_TARGETS_UP
0.00920 0.00008 0.02087GRUETZMANN_PANCREATIC_CANCER_UP
0.03767 0.00570 0.08611NCI_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.04102 0.04117 0.00002OKUMURA_INFLAMMATORY_RESPONSE_LPS
0.04333 0.00809 0.13298NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION1
0.05741 0.00367 0.00631KEGG_PROTEASOME
0.06587 0.13990 0.00010LEE_LIVER_CANCER_HEPATOBLAST
0.00045 0.00000 0.00003NAGASHIMA_EGF_SIGNALING_UP
0.01300 0.00001 0.00082AMIT_DELAYED_EARLY_GENES
0.00090 0.00004 0.00000AMIT_EGF_RESPONSE_60_MCF10A
0.17017 0.00000 0.00018NOJIMA_SFRP2_TARGETS_UP
0.02120 0.13983 0.15777WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN
0.01846 0.00079 0.13852CHEN_HOXA5_TARGETS_6HR_UP
0.01878 0.00000 0.00000OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.15695 0.04081 0.00732NCI_TCRCALCIUMPATHWAY
0.01189 0.00000 0.01400SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.04385 0.00000 0.02992NETPATH_EGFR1_PATHWAY_DOWN
0.16924 0.02135 0.05537RODWELL_AGING_KIDNEY_NO_BLOOD_UP
0.17901 0.17622 0.15951NCI_PDGFRAPATHWAY
0.02448 0.01698 0.01801RODRIGUES_THYROID_CARCINOMA_DN
0.11228 0.01619 0.00288NCI_NFKAPPABATYPICALPATHWAY
0.09853 0.02143 0.04805SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP
0.19264 0.01367 0.10854LEE_LIVER_CANCER_DENA_UP
0.02527 0.01212 0.00001HALMOS_CEBPA_TARGETS_UP
0.00050 0.02779 0.00033WU_CELL_MIGRATION
0.16355 0.00294 0.05591YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.15824 0.00956 0.00634CHANDRAN_METASTASIS_DN
0.00652 0.00500 0.09432BEIER_GLIOMA_STEM_CELL_DN
0.01436 0.01211 0.00015ONDER_CDH1_SIGNALING_VIA_CTNNB1
0.08538 0.00109 0.12193CAIRO_HEPATOBLASTOMA_CLASSES_DN
0.04993 0.01382 0.01179GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.15502 0.00000 0.00317MAHADEVAN_RESPONSE_TO_MP470_DN
0.10988 0.00753 0.00337DORN_ADENOVIRUS_INFECTION_12HR_DN
0.04421 0.17085 0.18318RIZKI_TUMOR_INVASIVENESS_2D_UP
0.08161 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.10031 0.00067 0.00034HARRIS_HYPOXIA
0.12500 0.00000 0.00002FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.02323 0.00022 0.00007KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP
0.04440 0.00571 0.02558KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.16976 0.19250 0.02526SWEET_LUNG_CANCER_KRAS_DN
0.13879 0.02074 0.00009XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.00722 0.01153 0.09232LAIHO_COLORECTAL_CANCER_SERRATED_UP
0.17791 0.02725 0.03253REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES
0.08229 0.02521 0.00037SOUCEK_MYC_TARGETS
0.04247 0.02077 0.07584GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP
0.05066 0.01866 0.14289BILBAN_B_CLL_LPL_DN
0.06594 0.00317 0.09546KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.04689 0.00047 0.00049IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.17440 0.19320 0.08643GENTILE_UV_LOW_DOSE_DN
0.08960 0.00000 0.00002ZHAN_MULTIPLE_MYELOMA_LB_DN
0.02403 0.00137 0.17340TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.07363 0.00130 0.00438KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION
0.09034 0.00240 0.00249SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM
0.00093 0.00000 0.00000BILD_HRAS_ONCOGENIC_SIGNATURE
0.11804 0.10243 0.05804FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN
0.01216 0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.03237 0.00000 0.00003DAUER_STAT3_TARGETS_UP
0.11860 0.00000 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.00004 0.00000 0.09188MENSE_HYPOXIA_UP
0.05921 0.00473 0.13289LEE_LIVER_CANCER_ACOX1_UP
0.02282 0.08977 0.00016BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.09462 0.00008 0.08973ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.02905 0.00000 0.00523AMIT_EGF_RESPONSE_60_HELA
0.04093 0.00008 0.09136PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.03619 0.01541 0.00004DAZARD_UV_RESPONSE_CLUSTER_G2
0.15653 0.00049 0.05781LEE_SP4_THYMOCYTE
0.00551 0.03519 0.08800AMUNDSON_RESPONSE_TO_ARSENITE
0.00737 0.00000 0.00142AMIT_SERUM_RESPONSE_40_MCF10A
0.07743 0.07090 0.05247GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN
0.07822 0.00601 0.15460HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP
0.00231 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.01834 0.00215 0.02986GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP
0.15203 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.13731 0.00036 0.01672SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.15156 0.01303 0.00002SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00297 0.00500 0.00002ONDER_CDH1_TARGETS_2_DN
0.05117 0.02665 0.11477NCI_REGULATION_OF_ORNITHINE_DECARBOXYLASE__ODC_
0.13021 0.00975 0.17726REACTOME_STABILIZATION_OF_P53
0.00075 0.00367 0.01395MANALO_HYPOXIA_UP
0.11522 0.00316 0.00040CASTELLANO_NRAS_TARGETS_UP
0.00067 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.03264 0.00552 0.00076SENESE_HDAC3_TARGETS_UP
0.01922 0.00107 0.00166VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP
0.00112 0.01103 0.00371CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.00000 0.00000 0.00044UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.06148 0.00239 0.00132XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.06149 0.13412 0.02283BIOCARTA_KERATINOCYTE_PATHWAY
0.04179 0.00000 0.00023JISON_SICKLE_CELL_DISEASE_UP
0.05639 0.00572 0.00009NCI_NFKAPPABCANONICALPATHWAY
0.08775 0.00469 0.05998XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.09369 0.00006 0.00015DASU_IL6_SIGNALING_UP
0.02097 0.00000 0.00000FARMER_BREAST_CANCER_CLUSTER_2
0.16635 0.00008 0.00000NETPATH_IL_2_PATHWAY_UP
0.03864 0.00002 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.15770 0.10077 0.03648BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.04796 0.00636 0.06877NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION
0.01824 0.00039 0.00000ZUCCHI_METASTASIS_DN
0.09293 0.01322 0.01079NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN
0.00087 0.06983 0.11099BRUECKNER_TARGETS_OF_MIRLET7A3_UP
0.15189 0.15108 0.02518BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP
0.01586 0.00812 0.01811DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.11265 0.04989 0.07582FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP